Astrazeneca

FromAstraZeneca ([email protected])
Subject (45)Datroway approved in US for EGFRm lung cancer
Preheader (113)Datroway approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
Typography
Arial
Colors
Text Analysis
Body Words124
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px734 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeOvernight

Datroway approved in US for EGFRm lung cancer

Datroway approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
Datroway approved in US for EGFRm lung cancer